Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia

Previous studies have shown that, the clinical features and prognosis of ZNF384-rearranged pediatric acute lymphoblastic leukemia (ALL) depend on its translocation partners. We report two cases of TCF4-ZNF384 fusion, one 6-year-old girl and one 10-year-old boy, both diagnosed by whole-transcriptome...

Full description

Bibliographic Details
Main Authors: Zhengyu Wu, Fang Zhang, Chengzhu Liu, Shuhong Shen, Jinhua Chu, Linhai Yang, Zhiwei Xie, Yu Liu, Kangkang Liu, Ningling Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.900054/full
_version_ 1798040090057900032
author Zhengyu Wu
Fang Zhang
Chengzhu Liu
Shuhong Shen
Shuhong Shen
Jinhua Chu
Linhai Yang
Zhiwei Xie
Yu Liu
Kangkang Liu
Ningling Wang
author_facet Zhengyu Wu
Fang Zhang
Chengzhu Liu
Shuhong Shen
Shuhong Shen
Jinhua Chu
Linhai Yang
Zhiwei Xie
Yu Liu
Kangkang Liu
Ningling Wang
author_sort Zhengyu Wu
collection DOAJ
description Previous studies have shown that, the clinical features and prognosis of ZNF384-rearranged pediatric acute lymphoblastic leukemia (ALL) depend on its translocation partners. We report two cases of TCF4-ZNF384 fusion, one 6-year-old girl and one 10-year-old boy, both diagnosed by whole-transcriptome sequencing, and TCF4 is the newest fusion partner of ZNF384. As illustrated in this first report of TCF4-ZNF384 fusion in ALL patients, the identification of patients with ZNF384 rearrangement in ALL patients is critical to elucidate outcomes associated with a specific rearrangement and to develop appropriate treatment strategies. In addition, the development of other methods to detect ZNF384 specific translocation partners and leukemia specific targeting agents is of great significance to further improve the prognosis of ALL with ZNF384-rearrangement.
first_indexed 2024-04-11T22:02:42Z
format Article
id doaj.art-e38ced66d0f74fb898ca44236fb0c1f7
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-11T22:02:42Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-e38ced66d0f74fb898ca44236fb0c1f72022-12-22T04:00:53ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.900054900054Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemiaZhengyu Wu0Fang Zhang1Chengzhu Liu2Shuhong Shen3Shuhong Shen4Jinhua Chu5Linhai Yang6Zhiwei Xie7Yu Liu8Kangkang Liu9Ningling Wang10Pediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPediatric Translational Medicine Institute, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPediatric Translational Medicine Institute, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaKey Laboratory of Pediatric Hematology & Oncology Ministry of Health, Department of Hematology & Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaKey Laboratory of Pediatric Hematology & Oncology Ministry of Health, Department of Hematology & Oncology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPediatrics, the Second Affiliated Hospital of Anhui Medical University, Hefei, ChinaPrevious studies have shown that, the clinical features and prognosis of ZNF384-rearranged pediatric acute lymphoblastic leukemia (ALL) depend on its translocation partners. We report two cases of TCF4-ZNF384 fusion, one 6-year-old girl and one 10-year-old boy, both diagnosed by whole-transcriptome sequencing, and TCF4 is the newest fusion partner of ZNF384. As illustrated in this first report of TCF4-ZNF384 fusion in ALL patients, the identification of patients with ZNF384 rearrangement in ALL patients is critical to elucidate outcomes associated with a specific rearrangement and to develop appropriate treatment strategies. In addition, the development of other methods to detect ZNF384 specific translocation partners and leukemia specific targeting agents is of great significance to further improve the prognosis of ALL with ZNF384-rearrangement.https://www.frontiersin.org/articles/10.3389/fonc.2022.900054/fullacute lymphoblastic leukemiaZNF384RNA sequencingTCF4pediatic
spellingShingle Zhengyu Wu
Fang Zhang
Chengzhu Liu
Shuhong Shen
Shuhong Shen
Jinhua Chu
Linhai Yang
Zhiwei Xie
Yu Liu
Kangkang Liu
Ningling Wang
Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
Frontiers in Oncology
acute lymphoblastic leukemia
ZNF384
RNA sequencing
TCF4
pediatic
title Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
title_full Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
title_fullStr Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
title_full_unstemmed Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
title_short Whole transcriptome sequencing reveals a TCF4-ZNF384 fusion in acute lymphoblastic leukemia
title_sort whole transcriptome sequencing reveals a tcf4 znf384 fusion in acute lymphoblastic leukemia
topic acute lymphoblastic leukemia
ZNF384
RNA sequencing
TCF4
pediatic
url https://www.frontiersin.org/articles/10.3389/fonc.2022.900054/full
work_keys_str_mv AT zhengyuwu wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT fangzhang wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT chengzhuliu wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT shuhongshen wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT shuhongshen wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT jinhuachu wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT linhaiyang wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT zhiweixie wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT yuliu wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT kangkangliu wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia
AT ninglingwang wholetranscriptomesequencingrevealsatcf4znf384fusioninacutelymphoblasticleukemia